20mins delayed


1 Year Return

Aroa Biosurgery Ltd Chart

Share price
Market Cap $444.11 million
Today's Movement
Prev. Close
Day Range -
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover

ARX Statistics

23 October

417 / 2,222

ASX Size Rank

1yr Return

vs Sector (1yr)


vs ASX 200 (1yr)


$444.11 million

Market Cap

Share Issue

300.07 million

All Ords (%)


Short Sold


Current Fundamentals

23 October


PE Ratio

EPS ($)


Earnings Yield


NTA ($)



Dividend Yield

DPS ($)


Gross Div. Yield


Gross DPS ($)


Company Overview

Aroa Biosurgery Limited (ARX) is a soft tissue regeneration company focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. It participates in the wound care and surgical reconstruction markets. Its products currently for sale in the key US market target chronic wounds and soft tissue reconstruction including, hernia, breast reconstruction and trauma/limb salvage/ tumour surgery.

Aroa Biosurgery Ltd Logo

Corporate Details

Head Office: Mangere Auckland
Managing Director: Brian Ward
GICS Sub-Industry: Biotechnology
Date Listed: 24 Jul 2020
Registry: -
Similar Companies: CSL / MSB / CUV / OPT / AVH

Upcoming Calendar

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.


Date Heading Pages File Size Time

Announcements provided by

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.









Broker Consensus data compiled by Market Index.

Directors & Management

About the Data

Name Title Since Bio
Mr John Flower Diddams Non-Executive Director Nov 2019
Mr Philip John McCaw Non-Executive Director Mar 2008
Mr James (Jim) Neil McLean Non-Executive Chairman, Non-Executive Director Aug 2011
Mr Steven (Steve) Barnard Engle Non-Executive Director Apr 2015
Mr John Richard Pinion II Non-Executive Director Feb 2015
Mr Brian Roderick Ward Chief Executive Officer, Managing Director Sep 2007
Ms Tracy Weimar Joint Company Secretary Jul 2020
Mr James Blair Agnew Chief Financial Officer, Joint Company Secretary -

Director Transactions

About the Data

ARX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code ARX in our database.

Shareholder Distribution

Shareholder Distribution data is unavailable.

Top 20 Shareholders

About the Data

Name Shares Capital
Brian Ward and Tracey Ward 33,125,800 11.04%
Movac Fund 3 Lp 25,841,850 8.61%
Phill Mccaw 16,722,425 5.57%
Richard Abbott 11,579,775 3.86%
Aspre Nz Seed Fund Ltd 10,332,407 3.44%
Sparkbox Investment Ltd 10,085,633 3.36%
National Nominees Limited 9,835,163 3.28%
HSBC Custody Nominees (Australia) Limited 9,227,800 3.08%
BNP Paribas Noms Pty Ltd 8,450,700 2.82%
Firetrail Investment Pty Ltd 6,374,625 2.12%
K One W One Ltd 6,359,475 2.12%
Mark Ritcher 6,016,350 2.00%
Mesynthes Nominee Ltd 5,354,175 1.78%
HSBC Custody Nominees (Australia) Limited A/C 2 4,919,267 1.64%
Sharon Bryant 4,815,198 1.60%
Washington H Soul Pattinson and Company Ltd 4,583,325 1.53%
Hollister Inc 4,268,840 1.42%
Nancy Yopp 3,913,842 1.30%
K One W One Ltd 3,881,342 1.29%
Movac Sidecar Fund Lp 3,864,750 1.29%
All other shareholders 36.85 %

The Top 20 Shareholders of ARX hold 63.15% of shares on issue.

ARX Share Price History

Date Close Change % Change Open High Low Volume Turnover

ARX Historical Data

Download up to 20 years of share price history.

Year Closing Price (30 June) Last Trade
2018 $0.30 29 June
2017 $0.515 28 June
2016 $0.45 28 June
2015 $0.001 30 June
2014 $0.003 30 June

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Designing and selling regenerative healing products.

Incorporated: --

2 Kingsford Smith Pl
Mangere Auckland New Zealand 2022

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.